Arkolith/Insider Trading/COGT/Form 4

Robbins Andrew R

President and CEO, DirectorCogent Biosciences, Inc. (COGT) · full profile →Form 4 · filed May 21, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 19, 2026Gift(G)160K—$0498K
May 19, 2026Gift(G)160K—$0160K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-234578) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML